Skip to main content

This Week in Virology featured three UNC-Chapel Hill researchers talking about READDI, a $125-million initiative designed to start making drugs now for the next pandemic.


This Week in Virology featured three UNC-Chapel Hill researchers talking about READDI, a $125-million initiative designed to start making drugs now for the next pandemic.

image2

Ralph Baric, the William R. Kenan, Jr. Distinguished Professor of Epidemiology at the UNC Gillings School of Global Public Health, Mark Heise, professor of genetics, and Nat Moorman, associate professor of microbiology and immunology — both at the UNC School of Medicine — discuss the non-profit initiative READDI, Rapidly Emerging Antiviral Drug Discovery Initiative, to start making drugs now for the next pandemic virus. Baric also holds a faculty appointment in the department of microbiology and immunology at the UNC School of Medicine.

Listen to the podcast at This Week in Virology.

You can read more about READDI here.